Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer (Q54597304)
Jump to navigation
Jump to search
scientific article published on April 11, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer |
scientific article published on April 11, 2011 |
Statements
Responses to Liposomal Doxorubicin, Bevacizumab, and Temsirolimus in Metaplastic Carcinoma of the Breast: Biologic Rationale and Implications for Stem-Cell Research in Breast Cancer (English)
1 reference
Razelle Kurzrock
Stacy Moulder
John Moroney
Thorunn Helgason
Jennifer Wheler
Daniel Booser
Constance Albarracin
Kimberly Koenig
Phuong K. Morrow
11 April 2011
29
19
e572-5
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference